1、 OH C E, ORTIZ-BRIZUELA E, BASTOS M L,et al. Comparing the diagnostic performance of QFT-Plus to other tests of latent tuberculosis infection:a systematic review and meta-analysis[J].Clin Infect Dis,2021,73(5):e1116-e1125. OH C E, ORTIZ-BRIZUELA E, BASTOS M L,et al. Comparing the diagnostic performance of QFT-Plus to other tests of latent tuberculosis infection:a systematic review and meta-analysis[J].Clin Infect Dis,2021,73(5):e1116-e1125.
2、 吴晓康,周维肖,冯楠,等.影响TB-IGRA检测结果的因素分析及应对措施[J].现代检验医学杂志,2018,33(4):154-156. 吴晓康,周维肖,冯楠,等.影响TB-IGRA检测结果的因素分析及应对措施[J].现代检验医学杂志,2018,33(4):154-156.
3、 WALSH M C,CAMERLIN A J,MILES R,et al. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes[J].Int J Tuberc Lung Dis,2011,15(2):179-84,i-iii. WALSH M C,CAMERLIN A J,MILES R,et al. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes[J].Int J Tuberc Lung Dis,2011,15(2):179-84,i-iii.
4、 KWON Y S,KIM Y H,JEON K,et al. Factors that predict negative results of QuantiFERON-TB Gold In-Tube test in patients with culture-confirmed tuberculosis:a multicenter retrospective cohort study[J].PLoS One,2015,10(6): e0129792. KWON Y S,KIM Y H,JEON K,et al. Factors that predict negative results of QuantiFERON-TB Gold In-Tube test in patients with culture-confirmed tuberculosis:a multicenter retrospective cohort study[J].PLoS One,2015,10(6): e0129792.
5、 SHINGADIA D, NOVELLI V.The tuberculin skin test:a hundred,not out?[J].Arch Dis Child,2008(93):189-190. SHINGADIA D, NOVELLI V.The tuberculin skin test:a hundred,not out?[J].Arch Dis Child,2008(93):189-190.
6、 FARHAT M, GREENAWAY C, PAI M, MENZIES D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?[J]. Int J Tuberc Lung Dis,2006,10(11):1192-1204. FARHAT M, GREENAWAY C, PAI M, MENZIES D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?[J]. Int J Tuberc Lung Dis,2006,10(11):1192-1204.
7、 国务院办公厅.国务院办公厅关于印发“十三五”全国结核病防治规划的通知[EB/OL].(2017-02-01)[2021-08-21]http://www.gov.cn/zhengce/content/2017-02/16/content_5168491.htm. 国务院办公厅.国务院办公厅关于印发“十三五”全国结核病防治规划的通知[EB/OL].(2017-02-01)[2021-08-21]http://www.gov.cn/zhengce/content/2017-02/16/content_5168491.htm.
8、 杨帆,胡良安.肺结核分子诊断方法研究进展[J].现代医药卫生,2020,36(22):3593-3597. 杨帆,胡良安.肺结核分子诊断方法研究进展[J].现代医药卫生,2020,36(22):3593-3597.
9、 BOEHME C C.Rapid molecular detection of tuberculosis and rifampin resistance[J].N Engl J Med,2010,363(11):1005-1015. BOEHME C C.Rapid molecular detection of tuberculosis and rifampin resistance[J].N Engl J Med,2010,363(11):1005-1015.
10、 FORBES B A,HALL G S,MILLER M B,et al. Practice guidelines for clinical microbiology laboratories: mycobacteria[J].Clin Microbiol Rev,2018,31(2):e00038-17. FORBES B A,HALL G S,MILLER M B,et al. Practice guidelines for clinical microbiology laboratories: mycobacteria[J].Clin Microbiol Rev,2018,31(2):e00038-17.
11、 RYU Y J. Diagnosis of pulmonary tuberculosis: recent advances and diagnostic algorithms[J].Tuberc Respir Dis(Seoul),2015,78(2):64-71. RYU Y J. Diagnosis of pulmonary tuberculosis: recent advances and diagnostic algorithms[J].Tuberc Respir Dis(Seoul),2015,78(2):64-71.
12、 张梅,焦祖伟,聂渝琼.我国结核病诊断方法现状与进展[J].中国卫生检验杂志,2011.21(12):3018-3020. 张梅,焦祖伟,聂渝琼.我国结核病诊断方法现状与进展[J].中国卫生检验杂志,2011.21(12):3018-3020.
13、 姚篙,方雪晖.《中国结核病预防控制工作技术规范(2020年版)》[J].热带病与寄生虫学,2020,18(3):138-141. 姚篙,方雪晖.《中国结核病预防控制工作技术规范(2020年版)》[J].热带病与寄生虫学,2020,18(3):138-141.
14、 中华人民共和国国家卫生和计划生育委员会.中华人民共和国卫生行业标准-肺结核诊断(WS 288-2017)[S].新发传染病电子杂志,2018,3(1):59-61. 中华人民共和国国家卫生和计划生育委员会.中华人民共和国卫生行业标准-肺结核诊断(WS 288-2017)[S].新发传染病电子杂志,2018,3(1):59-61.
15、 WHO.GLOBAL TUBERCULOSIS REPORT 2020[R/OL].(2020-10-15)[2021-08-21]https://www.who.int/publications/i/item/9789240013131. WHO.GLOBAL TUBERCULOSIS REPORT 2020[R/OL].(2020-10-15)[2021-08-21]https://www.who.int/publications/i/item/9789240013131.